The kitchen counter used to mean Sunday mornings. I would stand there slicing up tomatoes, onions, and other vegetables. And as the sharp smell rose,…
Myeloma
A Phase 1 clinical trial testing the experimental therapy KLN-1010 in people with relapsed or refractory multiple myeloma has begun treating patients in the…
I used to say if I needed to take a pill every day to survive, I’d be dead in a week. So it felt like…
Some mornings, I slip into borrowed strength the way other people put on a coat. Others might wonder why I do this. After all, I’m…
Cellcentric has raised $220 million in financing to support two clinical trials testing its potentially first-in-class oral therapy inobrodib in people with hard-to-treat…
My very first journalism teacher, way back in high school, taught me the importance of “who, what, when, where, and why” as building blocks of…
When I wake up some mornings, I check on my mum to see how she’s faring. Then I mentally review two different calendars. One of…
Gilead said it has completed its $7.8 billion acquisition of Arcellx, a deal the company hopes will allow it to streamline and accelerate the…
Note: This column describes the author’s experience with Revlimid (lenalidomide). Not everyone will have the same response to treatment. Consult your doctor before starting or…
Some days when I’m caregiving for my mum, I’ve noticed that the hardest part isn’t what one might expect. The hardest part doesn’t have anything…
Recent Posts
- FDA approves cell therapy to reduce GVHD risk after transplant
- Regulators in 2 countries OK clinical testing of new blood cancer treatment
- The changing details of my mother’s hands tell her life story
- Glioblastoma trial adds new drug in search for better treatments
- Protein marker may help predict myeloma outcomes
